Quarterly report pursuant to Section 13 or 15(d)

Impairment charges of patents (Details)

v2.4.0.6
Impairment charges of patents (Details) (USD $)
Mar. 31, 2013
Impairment charges representing unamortized basis of patents related to ProAlgaZyme $ 6,234